Inspire Medical Systems, Inc. INSP
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 200.58M | 204.58M | 269.08M | 224.50M | 217.09M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 200.58M | 204.58M | 269.08M | 224.50M | 217.09M |
| Cost of Revenue | 29.12M | 27.67M | 36.07M | 31.77M | 34.67M |
| Gross Profit | 171.46M | 176.91M | 233.01M | 192.73M | 182.41M |
| SG&A Expenses | 147.28M | 152.20M | 161.95M | 158.87M | 159.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 201.10M | 205.70M | 222.97M | 214.86M | 220.40M |
| Operating Income | -514.00K | -1.12M | 46.11M | 9.64M | -3.32M |
| Income Before Tax | 3.12M | 2.40M | 50.32M | 13.55M | -2.33M |
| Income Tax Expenses | 2.80M | 13.69M | -85.77M | 3.62M | 1.26M |
| Earnings from Continuing Operations | 314.00K | -11.29M | 136.09M | 9.93M | -3.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 314.00K | -11.29M | 136.09M | 9.93M | -3.59M |
| EBIT | -514.00K | -1.12M | 46.11M | 9.64M | -3.32M |
| EBITDA | 4.08M | 3.99M | 49.93M | 13.32M | 98.00K |
| EPS Basic | 0.01 | -0.39 | 4.70 | 0.34 | -0.12 |
| Normalized Basic EPS | 0.07 | 0.05 | 1.00 | 0.37 | 0.04 |
| EPS Diluted | 0.01 | -0.39 | 4.66 | 0.34 | -0.12 |
| Normalized Diluted EPS | 0.07 | 0.05 | 0.99 | 0.37 | 0.04 |
| Average Basic Shares Outstanding | 28.84M | 28.70M | 28.94M | 29.33M | 29.51M |
| Average Diluted Shares Outstanding | 28.94M | 28.70M | 29.22M | 29.60M | 29.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |